Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Embecta Corp., 3 years.
Embecta Corp.
Director
AtriCure Inc.
Director
Outset Medical Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Outset Medical Inc. June 4, 202696.0%
-
AtriCure Inc. May 18, 202698.6%
-
Embecta Corp. February 11, 202699.5%
-
AtriCure Inc. May 19, 202593.5%
-
AtriCure Inc. May 13, 202495.6%
-
Embecta Corp. February 7, 202499.5%
-
AtriCure Inc. May 25, 202395.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | AtriCure Inc. | Open-market sale | −3,564 | $38.80 | $138,283 |
| Jun 4, 2026 | Outset Medical Inc. | Grant or award | +10,667 | — | — |
| May 20, 2026 | AtriCure Inc. | Open-market sale | −3,000 | $28.65 | $85,950 |
| May 18, 2026 | AtriCure Inc. | Grant or award | +6,144 | — | — |
| Feb 11, 2026 | Embecta Corp. | Grant or award | +22,841 | — | — |
| Jan 9, 2026 | Outset Medical Inc. | Grant or award | +18,667 | — | — |
| May 19, 2025 | AtriCure Inc. | Grant or award | +5,401 | — | — |
| Mar 5, 2025 | AtriCure Inc. | Open-market sale | −6,100 | $38.12 | $232,532 |
| Feb 12, 2025 | Embecta Corp. | Grant or award | +13,839 | — | — |
| May 13, 2024 | AtriCure Inc. | Grant or award | +7,788 | — | — |
| Feb 7, 2024 | Embecta Corp. | Grant or award | +11,455 | — | — |
| Jun 8, 2023 | AtriCure Inc. | Open-market sale | −713 | $47.89 | $34,146 |
| May 25, 2023 | AtriCure Inc. | Grant or award | +3,186 | — | — |
| Feb 9, 2023 | Embecta Corp. | Grant or award | +6,979 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.